| BSE: 532523 | Sector: Health care |
| NSE: BIOCON | ISIN Code: INE376G01013 |
| BSE 00:00 | 28 Feb | 286.95 |
-12.25 (-4.09%) |
OPEN
290.30 |
HIGH
294.90 |
LOW
285.50 |
| NSE 00:00 | 28 Feb | 286.90 |
-12.00 (-4.01%) |
OPEN
292.45 |
HIGH
294.90 |
LOW
285.00 |
| OPEN | 290.30 |
| PREVIOUS CLOSE | 299.20 |
| VOLUME | 146063 |
| 52-Week high | 323.30 |
| 52-Week low | 211.30 |
| P/E | 113.42 |
| Mkt Cap.(Rs cr) | 34,434 |
| Buy Price | 286.95 |
| Buy Qty | 25.00 |
| Sell Price | 290.10 |
| Sell Qty | 5.00 |
8.41 pm | 27 Feb 2020 | Press Trust of India
Biocon shares on Thurday ended 0.17 per cent up at Rs 299.20 apiece on the BSE.
4.01 pm | 24 Feb 2020 | Business Standard
All that happened in markets today
12.03 pm | 24 Feb 2020 | Business Standard
The stock of India's biggest biotechnology company was trading higher for the third straight day, and has surpassed it's previous high of Rs 321 touch...
11.26 pm | 29 Jan 2020 | Business Standard
Ramp-up and new biosimilars should help boost profit
11.06 am | 27 Jan 2020 | Press Trust of India
Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of the API man...
9.53 pm | 24 Jan 2020 | Business Standard
The company is uniquely positioned in the US as it is the only Indian pharmaceutical firm with two commercialised biosimilars in the market
4.21 pm | 24 Jan 2020 | Business Standard
All that happened in the markets today
2.48 pm | 24 Jan 2020 | Business Standard
The consolidated Ebitda margin stood at 27% in Q3FY20.
8.45 am | 24 Jan 2020 | Business Standard
Here's a look at the top stocks that may remain in focus today -
4.16 pm | 23 Jan 2020 | Business Standard
All that happened in the markets today
9.05 am | 23 Jan 2020 | Business Standard
Here's a look at the top stocks that may remain in focus today.
8.18 am | 17 Jan 2020 | Business Standard
Biocon has maintained a strong base near 280 levels which is a good support level and currently has indicated a positive bullish candle pattern to imp...
9.08 am | 6 Jan 2020 | Business Standard
Here's a look at the top stocks that may trade actively in today's trading session.
8.52 am | 13 Dec 2019 | Business Standard
Here's a list of companies whose shares are expected to trade actively in today's session.
11.52 pm | 4 Dec 2019 | Business Standard
Even as the Street will monitor product ramp-up, commercialisation of more biosimilars will drive prospects further
7.15 pm | 3 Dec 2019 | Business Standard
Mittal takes over from Arun Chandavarkar, who retired on November 30 after 29 years at Biocon
9.56 am | 3 Dec 2019 | Business Standard
Ogivri is used to treat breast cancer and gastric cancer and Biocon has regulatory approval to sell it in more than 80 countries worldwide.
9.03 am | 3 Dec 2019 | Business Standard
Here's a list of stocks that may remain in focus today.
1.10 pm | 28 Nov 2019 | Business Standard
The US Food and Drug Administration's (USFDA's) nod to Biocon's supplemental biologics licence application for the new unit will expand the company's ...
12.44 pm | 27 Nov 2019 | Press Trust of India
Biocon Biologics, through its partner Mylan, has commercialised three of its co-developed biosimilars in developed markets like the US, Canada, the Eu...
